Scorpius has created a stand-alone building for microbial biomanufacturing on its campus in San Antonio, Texas. With ~3,200 sq. ft. dedicated to microbial cGMP biomanufacturing, the microbial facility is comprised of two segregated Grade C cleanroom suites, upstream and downstream, featuring modular design and dedicated air handling units. It utilises single-use technologies to mitigate contamination risk and to speed up suite turnaround between production runs.
Scorpius can produce clinical-scale and small-scale commercial products for recombinant microbial proteins, plasmid DNA, therapeutic enzymes, immune toxins, and bacterial subunit vaccines.
The Scorpius leadership team over 100 years of industry experience. Their expertise in process development includes optimising microbial fermentation yields, mechanical and chemical cell lysis processes, product recovery, as well as downstream plasmid and protein recovery operations.
